A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.

Why are some filings missing?

New filings appear as the SEC updates EDGAR, and older records can vary by availability.

How often is this page updated?

Updates follow new EDGAR submissions and periodic data refreshes.

SEC EDGAR filings, ownership reports, and insider transactions for Na Yeon Kim.

Business address: C/O Neurobo Pharmaceuticals, Inc., 177 Huntington Avenue, Suite 1700, Boston, MA, 02115
Top holdings (ownership): NRBO

Get insider transactions for this reporting owner

Na Yeon Kim has filed 7 SEC EDGAR filings since 02 Jan 2020

Recent SEC filings for Na Yeon Kim including 4, 4/A, 3.

Form type	Document	Filing	Description	Filing date	Reporting date	File number(s)
4	Open 4 document	View SEC filing for 4	OWNERSHIP DOCUMENT	28 Jul 2023	27 Jul 2023	001-37809
4/A	Open 4/A document	View SEC filing for 4/A	OWNERSHIP DOCUMENT	28 Jul 2023	26 Jul 2022	001-37809
4	Open 4 document	View SEC filing for 4	OWNERSHIP DOCUMENT	28 Jul 2022	26 Jul 2022	001-37809
4	Open 4 document	View SEC filing for 4	OWNERSHIP DOCUMENT	13 Jun 2022	09 Jun 2022	001-37809
4	Open 4 document	View SEC filing for 4		15 Jan 2020	13 Jan 2020	001-37809
4	Open 4 document	View SEC filing for 4		02 Jan 2020	30 Dec 2019	001-37809
3	Open 3 document	View SEC filing for 3		02 Jan 2020	30 Dec 2019	001-37809

Na Yeon Kim files with the SEC under CIK 0001794779. This page aggregates EDGAR filings and related ownership activity.

What is a CIK?: A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?: New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?: Updates follow new EDGAR submissions and periodic data refreshes.